36501032|t|p-Hydroxybenzyl Alcohol Antagonized the ROS-Dependent JNK/Jun/Caspase-3 Pathway to Produce Neuroprotection in a Cellular Model of Parkinson's Disease.
36501032|a|Parkinson's disease (PD) is a progressive disorder that affects brain nerve cells responsible for body motion and remains incurable. p-Hydroxybenzyl alcohol (HBA) is the primary phenolic compound in Gastrodiae Rhizoma, known for its therapeutic benefits against neurodegeneration. However, the protective effect of HBA against Parkinson's disease (PD) remains unclear. The objective of this study was to evaluate the neuroprotective effects of HBA in vitro 6-hydroxydopamine (6-OHDA)-induced PD model in SH-SY5Y cells. SH-SY5Y cells were pretreated with various concentrations of HBA for 1 h and incubated with 100 mumol/L 6-OHDA for 24 h to induce cellular lesions. 2,5-Diphenyl-2H-tetrazolium bromide was used to detect cellular viability. 2',7'-dichlorofluorescin oxidation detects reactive oxygen species (ROS). The enzyme-linked immunosorbent assay was used to determine the activities of superoxide dismutase, catalase, and glutathione peroxidase. The cellular mitochondrial function was identified through the collapse of the mitochondrial membrane potential, the release of cytochrome c, and the synthesis of mitochondrial ATP. Expression of pro-and anti-apoptotic factors was measured by Western blot. HBA enhanced cell viability, blocked ROS overproduction, and reduced antioxidant activities induced by 6-OHDA. HBA also reduced mitochondrial dysfunction and cell death caused by 6-OHDA. Moreover, HBA reversed the 6-OHDA-mediated activation of c-Jun N-terminal kinase, the downregulation of the Bcl-2/Bax ratio, the Apaf-1 upregulation and the induction of caspase-9, caspase-3, and PARP cleavage. This study shows that the protective effects of HBA against 6-OHDA-induced cell injury provide the potential preventive effects of HBA, making it a promising preventive agent for PD.
36501032	0	23	p-Hydroxybenzyl Alcohol	Chemical	MESH:C018966
36501032	40	43	ROS	Chemical	MESH:D017382
36501032	54	57	JNK	Gene	5599
36501032	62	71	Caspase-3	Gene	836
36501032	112	120	Cellular	Disease	MESH:D004806
36501032	130	149	Parkinson's Disease	Disease	MESH:D010300
36501032	151	170	Parkinson's disease	Disease	MESH:D010300
36501032	172	174	PD	Disease	MESH:D010300
36501032	284	307	p-Hydroxybenzyl alcohol	Chemical	MESH:C018966
36501032	309	312	HBA	Chemical	MESH:C018966
36501032	329	346	phenolic compound	Chemical	-
36501032	413	430	neurodegeneration	Disease	MESH:D019636
36501032	466	469	HBA	Chemical	MESH:C018966
36501032	478	497	Parkinson's disease	Disease	MESH:D010300
36501032	499	501	PD	Disease	MESH:D010300
36501032	595	598	HBA	Chemical	MESH:C018966
36501032	608	625	6-hydroxydopamine	Chemical	MESH:D016627
36501032	627	633	6-OHDA	Chemical	MESH:D016627
36501032	643	645	PD	Disease	MESH:D010300
36501032	655	662	SH-SY5Y	CellLine	CVCL:0019
36501032	670	677	SH-SY5Y	CellLine	CVCL:0019
36501032	731	734	HBA	Chemical	MESH:C018966
36501032	774	780	6-OHDA	Chemical	MESH:D016627
36501032	800	808	cellular	Disease	MESH:D004806
36501032	818	853	2,5-Diphenyl-2H-tetrazolium bromide	Chemical	-
36501032	873	881	cellular	Disease	MESH:D004806
36501032	893	917	2',7'-dichlorofluorescin	Chemical	MESH:C037631
36501032	936	959	reactive oxygen species	Chemical	MESH:D017382
36501032	961	964	ROS	Chemical	MESH:D017382
36501032	1067	1075	catalase	Gene	847
36501032	1109	1117	cellular	Disease	MESH:D004806
36501032	1233	1245	cytochrome c	Gene	54205
36501032	1282	1285	ATP	Chemical	MESH:D000255
36501032	1362	1365	HBA	Chemical	MESH:C018966
36501032	1399	1402	ROS	Chemical	MESH:D017382
36501032	1465	1471	6-OHDA	Chemical	MESH:D016627
36501032	1473	1476	HBA	Chemical	MESH:C018966
36501032	1490	1515	mitochondrial dysfunction	Disease	MESH:D028361
36501032	1541	1547	6-OHDA	Chemical	MESH:D016627
36501032	1559	1562	HBA	Chemical	MESH:C018966
36501032	1576	1582	6-OHDA	Chemical	MESH:D016627
36501032	1657	1662	Bcl-2	Gene	596
36501032	1663	1666	Bax	Gene	581
36501032	1678	1684	Apaf-1	Gene	317
36501032	1719	1728	caspase-9	Gene	842
36501032	1730	1739	caspase-3	Gene	836
36501032	1745	1749	PARP	Gene	1302
36501032	1808	1811	HBA	Chemical	MESH:C018966
36501032	1820	1826	6-OHDA	Chemical	MESH:D016627
36501032	1835	1846	cell injury	Disease	MESH:D002280
36501032	1891	1894	HBA	Chemical	MESH:C018966
36501032	1939	1941	PD	Disease	MESH:D010300
36501032	Association	MESH:D004806	54205
36501032	Association	MESH:D017382	5599
36501032	Association	MESH:D010300	5599
36501032	Negative_Correlation	MESH:C018966	836
36501032	Positive_Correlation	MESH:D016627	842
36501032	Positive_Correlation	MESH:D016627	MESH:D028361
36501032	Positive_Correlation	MESH:D016627	MESH:D004806
36501032	Association	MESH:C037631	MESH:D017382
36501032	Association	MESH:D016627	1302
36501032	Association	MESH:D016627	836
36501032	Association	MESH:D010300	836
36501032	Negative_Correlation	MESH:C018966	596
36501032	Negative_Correlation	MESH:C018966	MESH:D002280
36501032	Association	MESH:C018966	1302
36501032	Positive_Correlation	MESH:D016627	MESH:D010300
36501032	Negative_Correlation	MESH:C018966	MESH:D028361
36501032	Negative_Correlation	MESH:C018966	MESH:D016627
36501032	Positive_Correlation	MESH:D016627	317
36501032	Positive_Correlation	MESH:C018966	842
36501032	Positive_Correlation	MESH:D016627	MESH:D002280
36501032	Association	MESH:D000255	MESH:D004806
36501032	Positive_Correlation	MESH:C018966	317
36501032	Negative_Correlation	MESH:C018966	5599
36501032	Association	MESH:D017382	836
36501032	Negative_Correlation	MESH:C018966	MESH:D010300
36501032	Negative_Correlation	MESH:C018966	581
36501032	Negative_Correlation	MESH:C018966	MESH:D017382
36501032	Negative_Correlation	MESH:C018966	MESH:D019636

